Cubitoll 20% subcutaneous injection 4g/20mL (YJ code: 6343439A5020, 4g 20mL 1 bottle), manufactured by Takeda Pharmaceutical, contains pH4 treated acidic human immunoglobulin (subcutaneous injection). This medication is indicated for replacement therapy in primary immunodeficiency diseases and as maintenance therapy for chronic inflammatory demyelinating polyneuropathy.
Cubitoll 20% subcutaneous injection 4g/20mL
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).